FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Peter C. Enzinger, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01747551
First received: December 5, 2012
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)